The Wistar Institute Board of Trustees approved the 2021-2026 Strategic Plan that will catalyze the Institute’s scientific excellence, innovation, and growth. The power of science has never been clearer, and Wistar, as a single mission non-profit biomedical research institute, will seize its moment to advance discovery research that delivers new solutions to combatting global health crises.
The five-year Plan is ambitious and clearly charts a course for Wistar to deliver on its commitments to bold and innovative science, to next-generation models of life sciences training and education, and to the creation of transformative global, national and local research collaborations.
“This blueprint reflects our Institute-wide commitment to push forward and deliver purposeful, impactful advances in three core areas that define us: scientific freedom to do the nimblest, technologically advanced science with a transformative impact on society and beyond; commitment to championing equity, diversity, and inclusion in unique education programs for students domestically and globally; and dedication to achieving more growth and success working with like-minded collaborators focused on biomedical research and technology to solve human health challenges,” says Dario Altieri, M.D., Wistar president and CEO, Cancer Center director, and Robert and Penny Fox Distinguished Professor. “There is no better time than now.”
The Institute will expand its NCI-designated Cancer Center and Vaccine & Immunotherapy Center through the recruitment of new and talented scientists having diverse perspectives and technological skillsets. During the next five years, Wistar will be expanding its footprint from 34 to 50 laboratories focused solely on cancer, infectious disease, and translational research to accelerate the development of novel therapeutics, vaccines and diagnostics.
Wistar will enhance its role as education innovator to train and engage diverse students. Our education programs have been recognized as models and will continue to expand and inspire the next generation of scientists, pushing the envelope of learning and access to science beyond geographical borders.
True to its unique and collaborative approach to science, Wistar will expand partnerships to innovate and evolve our high-risk, high-reward scientific research across cancer, infectious disease and translational research disciplines.